Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

被引：4

作者：

Sugai, Fuminobu ^{[1
]}

Kokunai, Yosuke ^{[1
]}

Yamamoto, Yoichi ^{[1
]}

Hashida, Goichi ^{[2
]}

Shimazu, Kengo ^{[2
]}

Mihara, Masahito ^{[1
]}

Inoue, Satoru ^{[2
]}

Sakoda, Saburo ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan

[2] Osaka Univ Hosp, Rehabil Unit, Osaka 553, Japan

来源：

JOURNAL OF NEUROLOGY | 2010年 / 257卷 / 03期

关键词：

Pompe disease; Late onset; Muscle volume analyzer; Bioelectric impedance; Handheld dynamometer;

D O I：

10.1007/s00415-009-5367-0

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.

引用

页码：461 / 463

页数：3

共 50 条

[31] Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: A case study
Case, Laura E.
Koeberl, Dwight D.
Young, Sarah P.
Bali, Deeksha
DeArmey, Stephanie M.
Mackey, Joanne
Kishnani, Priya S.
MOLECULAR GENETICS AND METABOLISM, 2008, 95 (04) : 233 - 235
[32] Clinical course of seven patients with late-onset Pompe disease receiving enzyme replacement therapy
Spranger, M.
Grunert, B.
CLINICAL THERAPEUTICS, 2007, 29 : S120 - S121
[33] First case of a patient with late-onset Pompe disease: Cardiomyopathy remission with enzyme replacement therapy
Ceron-Rodriguez, Magdalena
Zamora, Antonio
Erdmenger, Julio
Urena, Roberto
Consuelo Sanchez, Alejandra
BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2014, 71 (01): : 41 - 46
[34] Respiratorymuscle trainingwith enzyme replacement therapy improves muscle strength in late - onset Pompe disease
Mitja, Jevnikar
Metka, Kodric
Fabiana, Cantarutti
Cifaldi, Rossella
Longo, Cinzia
Rossana, Della Porta
Bruno, Bembi
Marco, Confalonieri
MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 : 67 - 71
[35] Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: The two sides of low BMI
Ravaglia, Sabrina
Carlucci, Annalisa
Danesino, Cesare
MOLECULAR GENETICS AND METABOLISM, 2010, 100 (04) : 388 - 388
[36] Initial therapeutic response to enzyme replacement therapy with Myozyme® in a sibling cohort with late-onset Pompe disease
Hughes, D. S.
Norwood, F.
Sawicka, E.
Milligan, A.
Pringle, S.
Bruce, R.
Goodwin, S.
Jennings, A.
Richfield, L.
Mehta, A. B.
CLINICAL THERAPEUTICS, 2008, 30 : S29 - S30
[37] Functional capacity in a late-onset Pompe disease patient: Effect of enzyme replacement therapy and exercise training
Krase, Argyro A.
Papadimas, Giorgos K.
Terzis, Gerasimos D.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2016, 19 (03) : 423 - U136
[38] Early signs of benefit in a child with late-onset Pompe disease after treatment with enzyme replacement therapy
Lianou, D.
Syrengelas, D.
Poulopoulos, P.
Klimentopoulou, A.
Mavridou, I.
Michelakakis, H.
CLINICAL THERAPEUTICS, 2007, 29 : S121 - S121
[39] Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease
Winkler, Maren
von Landenberg, Christina
Kuchenbecker, Katharina
Reimann, Jens
Kornblum, Cornelia
NEUROMUSCULAR DISORDERS, 2022, 32 (03) : 195 - 205
[40] Enzyme replacement therapy induces T-cell responses in late-onset Pompe's disease
Banati, M.
Hosszu, Z.
Trauninger, A.
Szereday, L.
Illes, Z.
JOURNAL OF NEUROLOGY, 2011, 258 : 253 - 253

← 1 2 3 4 5 →